Last reviewed · How we verify
Human Cadaver Allograft
At a glance
| Generic name | Human Cadaver Allograft |
|---|---|
| Also known as | Human Allograft Skin, HCA |
| Sponsor | XenoTherapeutics, Inc. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- AFS Compared to AHC in Treatment of Necrotizing Fasciitis NF (PHASE4)
- Evaluation of Safety and Efficacy of realSKIN® (Skin Xenotransplant) for Complete Closure of Severe Burn Wounds (PHASE1, PHASE2)
- A Randomized, Controlled Trial Comparing the Use of a Biodegradable Temporizing Matrix to Cadaver Skin in the Reconstruction of Hidradenitis Suppurativa Excisions (PHASE4)
- The Relationship Between Cadaveric Allograft Skin and HLA-Sensitivity in Burn Patients (PHASE4)
- Permeaderm Versus Homograft for Full-thickness Burns (NA)
- StrataGraft™ Skin Tissue (Human Donor Skin) In The Surgical Management Of Complex Skin Defects (PHASE1, PHASE2)
- Evaluation of Amnion Chorion Membrane and Demineralized Bone Matrix Putty Allograft in Periodontal Intrabony Defects (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |